Acquisitions and Divestitures - Acquired Intangible Assets and Related Estimated Useful Lives (Detail) - USD ($)
$ in Thousands |
1 Months Ended |
12 Months Ended |
May. 31, 2015 |
Sep. 30, 2014 |
Aug. 31, 2014 |
Aug. 31, 2013 |
Dec. 31, 2015 |
| Business Acquisition [Line Items] |
|
|
|
|
|
| Weighted average useful life |
|
|
|
|
6 years
|
| InaVein LLC [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
|
$ 1,143
|
|
| InaVein LLC [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
|
$ 70
|
|
| Weighted average useful life |
|
|
|
5 years
|
|
| InaVein LLC [Member] | Trade Name [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
|
$ 163
|
|
| Weighted average useful life |
|
|
|
8 years
|
|
| InaVein LLC [Member] | Technology [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
|
$ 354
|
|
| Weighted average useful life |
|
|
|
6 years
|
|
| InaVein LLC [Member] | Customer Relationships [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
|
$ 556
|
|
| Weighted average useful life |
|
|
|
7 years
|
|
| Xenotis Pty Ltd [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
$ 1,794
|
|
|
| Xenotis Pty Ltd [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
$ 135
|
|
|
| Weighted average useful life |
|
|
5 years
|
|
|
| Xenotis Pty Ltd [Member] | Trade Name [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
$ 142
|
|
|
| Weighted average useful life |
|
|
7 years
|
|
|
| Xenotis Pty Ltd [Member] | Technology [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
$ 1,465
|
|
|
| Weighted average useful life |
|
|
7 years
|
|
|
| Xenotis Pty Ltd [Member] | Customer Relationships [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
|
$ 52
|
|
|
| Weighted average useful life |
|
|
7 years
|
|
|
| AngioScope [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
$ 276
|
|
|
|
| AngioScope [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
$ 3
|
|
|
|
| Weighted average useful life |
|
2 years
|
|
|
|
| AngioScope [Member] | Trade Name [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
$ 28
|
|
|
|
| Weighted average useful life |
|
7 years
|
|
|
|
| AngioScope [Member] | Technology [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
$ 163
|
|
|
|
| Weighted average useful life |
|
7 years
|
|
|
|
| AngioScope [Member] | Customer Relationships [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
|
$ 82
|
|
|
|
| Weighted average useful life |
|
9 years
|
|
|
|
| Tru-Incise Valvulotome [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
$ 545
|
|
|
|
|
| Tru-Incise Valvulotome [Member] | Non-Compete Agreement [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
$ 120
|
|
|
|
|
| Weighted average useful life |
5 years
|
|
|
|
|
| Tru-Incise Valvulotome [Member] | Technology [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
$ 391
|
|
|
|
|
| Weighted average useful life |
7 years
|
|
|
|
|
| Tru-Incise Valvulotome [Member] | Customer Relationships [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
$ 17
|
|
|
|
|
| Weighted average useful life |
3 years
|
|
|
|
|
| Tru-Incise Valvulotome [Member] | Tradename License [Member] |
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
| Allocated fair value |
$ 17
|
|
|
|
|
| Weighted average useful life |
3 years
|
|
|
|
|